Cargando…

Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax

The antibody responses elicited by immunization of humans with vaccinia virus (VACV) strains Lister, Dryvax and NYVAC have been determined and compared. Neutralizing antibodies against intracellular mature virus (IMV) and extracellular enveloped virus (EEV), and binding antibody titres (ELISA) again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Midgley, Claire M., Putz, Mike M., Weber, Jonathan N., Smith, Geoffrey L.
Formato:	Texto
Lenguaje:	English
Publicado:	Society for General Microbiology 2008
Materias:	Animal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885029/ https://www.ncbi.nlm.nih.gov/pubmed/19008384 http://dx.doi.org/10.1099/vir.0.2008/004440-0

Ejemplares similares

Features of the Antitumor Effect of Vaccinia Virus Lister Strain
por: Zonov, Evgeniy, et al.
Publicado: (2016)

Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil
por: Assis, Felipe, et al.
Publicado: (2016)

Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours
por: Hiley, Crispin T, et al.
Publicado: (2009)

Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
por: Sumner, Rebecca P., et al.
Publicado: (2013)

Genome Sequence of WAU86/88-1, a New Variant of Vaccinia Virus Lister Strain from Poland
por: Mavian, Carla, et al.
Publicado: (2014)

Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
por: Tysome, James R, et al.
Publicado: (2009)

Improved NYVAC-Based Vaccine Vectors
por: Kibler, Karen V., et al.
Publicado: (2011)

Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein
por: Breiman, Adrien, et al.
Publicado: (2010)

Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions
por: Doceul, Virginie, et al.
Publicado: (2012)

Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
por: Maluquer de Motes, Carlos, et al.
Publicado: (2014)

Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein
por: Breiman, Adrien, et al.
Publicado: (2013)

A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism
por: Mazzon, Michela, et al.
Publicado: (2015)

Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response
por: Froggatt, Graham C., et al.
Publicado: (2007)

Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence
por: Ember, Stuart W. J., et al.
Publicado: (2012)

Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection
por: Benfield, Camilla T. O., et al.
Publicado: (2013)

Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
por: Ferguson, Brian J., et al.
Publicado: (2013)

Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3
por: Valentine, Robert, et al.
Publicado: (2010)

The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds
por: Gao, William N. D., et al.
Publicado: (2022)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012)

Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection
por: Jacobs, Nathalie, et al.
Publicado: (2008)

Lister
Publicado: (1912)

Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
por: Nájera, José Luis, et al.
Publicado: (2010)

Correction for Kibler et al., “Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC”
por: Kibler, Karen V., et al.
Publicado: (2019)

Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection
por: Veyer, David L., et al.
Publicado: (2014)

Lord Lister: XI. London's Indifference to Listerism
Publicado: (1918)

Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane
por: Roberts, Kim L., et al.
Publicado: (2009)

Optimization of translation enhancing element use to increase protein expression in a vaccinia virus system
por: Richard Jr., Harold B., et al.
Publicado: (2021)

Lord Lister: VI. Lister's Hypothesis of the Cause of Suppuration
Publicado: (1918)

P17-07. Insertion of a vaccinia virus host range (hr) gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens
por: Najera, JL, et al.
Publicado: (2009)

LORD LISTER
Publicado: (1950)

Lister and the Ligature
Publicado: (1926)

Lord Lister
Publicado: (1925)

Lister: An Appreciation
por: Roxburgh, Robert
Publicado: (1912)

The Lister Jubilee
Publicado: (1903)

Lord Lister
Publicado: (1912)

Lord Lister
Publicado: (1898)

Lord Lister
Publicado: (1897)

Ovariotomy and Listerism
Publicado: (1890)

Lord Lister
por: Cameron, Hector Clare
Publicado: (1924)

Professor Lister
Publicado: (1877)

Cannot write session to /tmp/vufind_sessions/sess_b63b1nl7ajoblou7cfokq0rs79